haematology
Coagulation

Early dabigatran use safe after minor stroke and TIA

Dabigatran appears to be feasible and safe in the management of non-AF associated acute ischaemic stroke or TIA, an Australian study shows. The phase 2 DATAS II study randomised 305 stroke /TIA patients to either dabigatran (mostly 150mg daily) or aspirin (81mg) for 30 days. The study, published in Stroke, reported that no patients in ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic